Electroencephalography (EEG) data processing to derive event-related potentials (ERPs) follows a standard set of procedures to maximize signal-to-noise ratio. This often includes ocular correction, which corrects for artifacts introduced by eye movements, typically measured by electrooculogram (EOG) using facial electrodes near the eyes. Yet, attaching electrodes to the face may be uncomfortable for some populations, best to avoid in some situations, and contribute to data loss. Eye movements can also be measured using electrodes in a standard 10-20 EEG cap. An examination of the impact of electrode selection on ERPs is needed to inform best practices. The present study examined data quality when using different electrodes to measure eye movements for ocular correction (i.e., facial electrodes, cap electrodes, and no ocular correction) for two well-established and widely studied ERP components (i.e., reward positivity, RewP; and late positive potential, LPP) elicited in adolescents (N = 34). Results revealed comparable split-half reliability and standardized measurement error (SME) between facial and cap electrode approaches, with lower SME for the RewP with facial or cap electrodes compared to no ocular correction. Few significant differences in mean amplitude of ERPs were observed, but the LPP to positive images differed when using facial compared to cap electrodes. Findings provide preliminary evidence of the ability to collect high-quality ERP data without facial electrodes. However, when using cap electrodes for EOG measurement and ocular correction, it is recommended to use consistent procedures across the sample or statistically examine the impact of ocular correction procedures on results.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10922232PMC
http://dx.doi.org/10.1111/psyp.14497DOI Listing

Publication Analysis

Top Keywords

ocular correction
28
cap electrodes
16
eye movements
12
facial electrodes
12
electrodes
10
impact electrode
8
electrode selection
8
reward positivity
8
late positive
8
positive potential
8

Similar Publications

Background: While vaccination remains crucial in mitigating the impact of the COVID-19 pandemic, several ocular adverse events has been reported, including Acute Zonal Occult Outer Retinopathy (AZOOR) complex.

Case Presentation: A 31-year-old female presented declined best corrected visual acuity (BCVA) and flashes in both eyes three days following second recombinant mRNA COVID-19 vaccine (Moderna). Fundus autofluorescence (FAF) illustrated speckled hyper-AF lesions surrounding right eye torpedo maculopathy site and hyper-AF lesions in the left macula.

View Article and Find Full Text PDF

Recent progress in CRISPR/Cas9 system for eye disorders.

Prog Mol Biol Transl Sci

January 2025

Graduate School of Biomedical Science and Engineering, Hanyang University, Seoul, South Korea; College of Medicine, Hanyang University, Seoul, South Korea. Electronic address:

Ocular disorders encompass a broad spectrum of phenotypic and clinical symptoms resulting from several genetic variants and environmental factors. The unique anatomy and physiology of the eye facilitate validation of cutting-edge gene editing treatments. Genome editing developments have allowed researchers to treat a variety of diseases, including ocular disorders.

View Article and Find Full Text PDF

Objective: To investigate the effects of minimally invasive strabismus surgery (MISS) on tear film function and ocular surface status in patients with strabismus.

Methods: We respectively analyzed the clinical data from 173 cases of strabismus patients treated at Xi'an First Hospital from September 2021 to March 2024. The patients were classified into a minimally invasive group (n=91, undergoing MISS) and a conventional group (n=82, undergoing traditional strabismus correction) according to their treatment plans.

View Article and Find Full Text PDF

Objective: To evaluate the therapeutic effects of Visual Training System 4 (VTS4) as an adjunctive therapy for patients with refractive amblyopia.

Method: A total of 82 patients with refractive amblyopia (142 eyes) treated at the Zhongshan Ophthalmic Center of Sun Yat-sen University, were enrolled and divided into two groups based on the treatment protocol. The control group included 40 patients (68 eyes) who received conventional comprehensive treatment, while the observation group was comprised of 42 patients (74 eyes) treated with VTS4 in addition to conventional therapy.

View Article and Find Full Text PDF

Publisher Correction: Preliminary investigation on the establishment of a new meibomian gland obstruction model and gene expression.

Sci Rep

January 2025

Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, 300384, China.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!